3F8

3F8
intravenous
ATC code	none;
Identifiers
CAS Number	339169-93-6 ;
ChemSpider	none;
UNII	3GFS72WN4M;
	(what is this?) (verify)

3F8 is a murine IgG3^[1] monoclonal antibody which binds to GD2.^[2]

It has been used in the detection and treatment of

iodine-124 and iodine-131.^[4]^[5]

References

PMID 2653466
.

^ "Sloan-Kettering - Neuroblastoma: 3F8 Monoclonal Antibody Therapy Q & A". Retrieved 2008-02-19.

S2CID 20705441
.

PMID 1902508
.

S2CID 25792466
.

v
t
e
Monoclonal antibodies for tumors
Tumor
Human

Adecatumumab^§

Amivantamab

Ascrinvacumab^§

Atezolizumab

Balstilimab^†

Botensilimab

Cixutumumab^§

Conatumumab^§

Daratumumab

Drozitumab^§

Duligotumab
^§

Dusigitumab^§

Enfortumab vedotin

Enoticumab^§

Figitumumab^§

Flanvotumab^§

Ganitumab^†

Glembatumumab vedotin^†

Intetumumab^§

Ipilimumab

Iratumumab^§

Istiratumab

Icrucumab^§

Lexatumumab^§

Lucatumumab^§

Mapatumumab^§

Narnatumab^§

Necitumumab

Nesvacumab^§

Nivolumab^#

Ofatumumab

Olaratumab^†

Panitumumab

Patritumab^§

Pembrolizumab^#

Pritumumab^§

Radretumab^§

Ramucirumab

Rilotumumab^†

Robatumumab^§

Seribantumab^§

Tarextumab^§

Tisotumab vedotin

Teprotumumab^†

Tovetumab^§

Vantictumab^§

Votumumab^§

Zalutumumab^†

Mouse

Abagovomab

Altumomab pentetate

Anatumomab mafenatox

Arcitumomab

Bectumomab

Blinatumomab

Capromab pendetide

Detumomab

Edrecolomab

Ibritumomab tiuxetan

Igovomab

Lilotomab

Minretumomab

Mitumomab

Nacolomab tafenatox

Moxetumomab pasudotox

Naptumomab estafenatox

Oregovomab

Pemtumomab^†

Racotumomab

Satumomab pendetide

Solitomab

Taplitumomab paptox

Nofetumomab merpentan

Pintumomab

Tenatumomab

Tositumomab

Chimeric

Amatuximab^§

Bavituximab^§

Brentuximab vedotin

Carotuximab^†

Cetuximab

Derlotuximab biotin^§

Dinutuximab

Ecromeximab^§

Ensituximab^§

Futuximab^§

Girentuximab^†

Indatuximab ravtansine^§

Isatuximab

Loncastuximab tesirine

Margetuximab

Mirvetuximab soravtansine

Rituximab^#

Siltuximab

Ublituximab

Zolbetuximab

Humanized

Abituzumab^§

Alemtuzumab

Belantamab mafodotin

Bevacizumab

Bivatuzumab mertansine^§

Brontictuzumab^§

Cantuzumab mertansine^§

Cantuzumab ravtansine^§

Cirmtuzumab

Citatuzumab bogatox^§

Clivatuzumab tetraxetan

Cofetuzumab pelidotin

Dacetuzumab^§

Demcizumab^§

Dalotuzumab^§

Denintuzumab mafodotin^§

Elotuzumab

Emactuzumab

Emibetuzumab^§

Enoblituzumab^§

Epcoritamab

Etaracizumab^§

Farletuzumab^§

Ficlatuzumab^§

Flotetuzumab^§

Gemtuzumab ozogamicin

Glofitamab

Imgatuzumab^§

Inotuzumab ozogamicin

Labetuzumab^§

Lifastuzumab vedotin^§

Lintuzumab^§

Lorvotuzumab mertansine^§

Lumretuzumab^§

Matuzumab^§

Milatuzumab^§

Naxitamab

Nimotuzumab^†

Obinutuzumab

Ocaratuzumab^§

Otlertuzumab^§

Onartuzumab^§

Oportuzumab monatox^†

Parsatuzumab^§

Pertuzumab

Pinatuzumab vedotin^§

Polatuzumab vedotin

Rosmantuzumab

Rovalpituzumab tesirine^†

Sacituzumab govitecan

Sibrotuzumab^§

Simtuzumab^§

Sofituzumab vedotin^§

Tacatuzumab tetraxetan^§

Tigatuzumab^§

Trastuzumab^# (+deruxtecan / +emtansine)

Tucotuzumab celmoleukin^§

Vandortuzumab vedotin^§

Vanucizumab^§

Veltuzumab^§

Vorsetuzumab mafodotin^§

Rat/mouse hybrid

Catumaxomab

Ertumaxomab^§

Chimeric + humanized

Depatuxizumab mafodotin^†

Duvortuxizumab

Ontuxizumab^§

^#WHO-EM

^‡Withdrawn from market

Clinical trials:
^†Phase III

^§Never to phase III

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.
v
t
e

drug article is a stub. You can help Wikipedia by expanding it.
v
t
e

[pmid2653466-1] PMID 2653466
.

[titleSloan-Kettering_-_Neuroblastoma:_3F8_Monoclonal_Antibody_Therapy_Q_&_A-2] "Sloan-Kettering - Neuroblastoma: 3F8 Monoclonal Antibody Therapy Q & A". Retrieved 2008-02-19.

[3] S2CID 20705441
.

[pmid1902508-4] PMID 1902508
.

[pmid17164597-5] S2CID 25792466
.

[1]

[2]

[4]

[5]

See also

References